Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

Clinical trial NCT06033118 · UNKNOWN

Trial details

NCT number: NCT06033118
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Combined Hepatocellular Cholangiocarcinoma

Start date: 2023-10-01
Primary completion: 2025-07-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.